clinical trials

Each week we highlight five things affecting the life sciences industry. Here’s the latest. FDA issues warnings on plastic syringes from China According to MedTech Dive, the U.S. Food and Drug Administration has issued three warning letters as part of its investigation into plastic syringes made in ... READ MORE >

This week we highlight a shortage of prescription medication in the United States. In addition, we discuss a Food and Drug Administration committee’s recommendation to approve a new RSV vaccine, comments on the Inflation Reduction Act impact, as well as a major acquisition in the diabetes space. Lastly, ... READ MORE >

This week we look at the Food and Drug Administration’s approval of an over-the-counter naloxone nasal spray, promising vaccines nearing approval to treat respiratory syncytial virus, and the FDA’s new guidance on diversity considerations for later-stage clinical trials. We also look at a new ... READ MORE >

It has been quite the year in life sciences as we try to define a new normal following the pandemic. While funding struggled, breakthroughs abounded. In addition, the Food and Drug Administration continued its work on drug pricing and clinical trial diversity. We can’t capture it all in one article, but ... READ MORE >